Order of the Vice-President of the Court of 29 April 2025.#Advanz Pharma Ltd v European Commission.#Appeal – Interim relief – Medicinal products for human use – Orphan medicinal product for human use Ocaliva – Revocation of a conditional marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case C-859/24 P(R).